Mitsubishi UFJ Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.3K Hold
362
﹤0.01% 1255
2026
Q1
$23.4K Hold
362
﹤0.01% 1208
2025
Q4
$25.5K Hold
362
﹤0.01% 1167
2025
Q3
$26.5K Hold
362
﹤0.01% 1129
2025
Q2
$18.8K Hold
362
﹤0.01% 1220
2025
Q1
$23.1K Hold
362
﹤0.01% 1122
2024
Q4
$17.3K Hold
362
﹤0.01% 1204
2024
Q3
$20.7K Buy
362
+277
+326% +$15.9K ﹤0.01% 1143
2024
Q2
$4.45K Hold
85
﹤0.01% 1399
2024
Q1
$3.46K Hold
85
﹤0.01% 1482
2023
Q4
$3.04K Hold
85
﹤0.01% 1521
2023
Q3
$3.25K Buy
+85
New +$3.48K ﹤0.01% 1424

Other funds holding HALO

Mitsubishi UFJ Asset Management's HALO Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management held its Halozyme (HALO) position steady in Q2 2026 at 362 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1255.

Mitsubishi UFJ Asset Management first reported a position in HALO in Q3 2023 and has held it in 12 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 362 shares of Halozyme worth $28.3K as of Q2 2026.
  • Mitsubishi UFJ Asset Management left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1255 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Halozyme in Q3 2023 and has held it in 12 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.